A common method for tumours to avoid CD95-mediated cell death is by reducing surface expression of the CD95 protein2, this eliminates apoptotic signals by preventing interaction with FasL but can be reversed with agents such as the nucleoside analogue 5-azacytidine if the downregulation of CD95 is caused by methylation of DNA3. The gene discussed is FASLG; the disease is neoplasm.